2m 2m 2m 2m 2m 2m 2m
- $87.00Market Cap
- 0.00%1-Year Change
- BiotechnologyIndustry
RenovaCare (RCAR)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 37
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Easy Renovation Study Reveals Toronto's Top Kitchen Renovation Companies in 2025
Easy Renovation released a study identifying the top 10 kitchen renovation companies in Toronto, highlighting firms that offer quality craftsmanship, transparent pricing, and exceptional client service amid rising renovation costs.
11/05/2025, 10:58 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 05/26/2026
Company Profile
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
Key Executives
- Justin Frere
- Jo Ellen Schweinle
- Harmel S. Rayat
Current Ownership Distribution
- Insiders100.4M (100.00%)
- Institutions5,000 (0.005%)
- Mutual Funds0 (0.00%)
- Other0 (0.00%)